DJIA 18,239.83 -45.91 -0.25%
NASDAQ 5,094.90 4.11 0.08%
S&P 500 2,127.25 -3.57 -0.17%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.12 -0.05 (-0.07%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $67.12 -0.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.84
Previous Close $67.17
Daily Range $66.61 - $67.69
52-Week Range $23.62 - $77.80
Market Cap $8.0B
P/E Ratio -335.85
Dividend (Yield) $0.00 (0.0%)
Volume 328,539
Average Daily Volume 2,351,186
Current FY EPS -$0.37




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

IWM, VGLT: Big ETF Inflows

Just What Is Invested Capital Anyway?


4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development

Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

Isis Pharmaceuticals' Q1 Loss Narrower than Expected - Analyst Blog

Isis Pharmaceuticals (ISIS) Earnings Report: Q1 2015 Conference Call Transcript

See More ISIS News...

ISIS's Top Competitors

ISIS $67.12 (-0.07%)
Current stock: ISIS
AMGN $163.37 (-0.29%)
Current stock: AMGN
GILD $112.23 (0.91%)
Current stock: GILD
BIIB $399.99 (-0.29%)
Current stock: BIIB